Literature DB >> 10770792

In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.

M R McGinnis1, N G Nordoff, N S Ryder, G B Nunn.   

Abstract

We evaluated terbinafine and itraconazole against 30 isolates of Penicillium marneffei using a modification of the National Committee for Clinical Laboratory Standards broth macrodilution MIC testing protocol for yeasts. The minimal fungicidal concentration (MFC) was determined by plating 100 microl from each MIC drug dilution having no growth onto Sabouraud glucose agar incubated at 30 degrees C. The MFC was the dilution at which growth was absent at 72 h of incubation. The MICs, in micrograms per milliliter, were as follows: terbinafine, 0.03 to 1.0 (geometric mean titer, 0.09); itraconazole, 0.03 to 0.5 (geometric mean titer, 0.04). The MFCs, in micrograms per milliliter, were as follows: terbinafine, 0.03 to 8 (geometric mean titer, 2.60); itraconazole, 0.03 to 8 (geometric mean titer, 2. 45). Primary fungicidal activity (MFC within 2 dilutions of MIC) was observed with terbinafine in eight isolates and with itraconazole in four isolates. The data indicate that terbinafine is active against P. marneffei in vitro and may have a previously unrealized role in the management of infections caused by this fungus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770792      PMCID: PMC89885          DOI: 10.1128/AAC.44.5.1407-1408.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen.

Authors:  C R Cooper; M R McGinnis
Journal:  Arch Pathol Lab Med       Date:  1997-08       Impact factor: 5.534

2.  In vitro evaluation of voriconazole against some clinically important fungi.

Authors:  M R McGinnis; L Pasarell; D A Sutton; A W Fothergill; C R Cooper; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.

Authors:  M R McGinnis; L Pasarell
Journal:  Med Mycol       Date:  1998-08       Impact factor: 4.076

4.  In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.

Authors:  J Boon-Long; N Mekha; N Poonwan; M Kusum; Y Mikami; K Yazawa; K Konyama
Journal:  Mycoses       Date:  1996 Nov-Dec       Impact factor: 4.377

5.  Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei.

Authors:  K F LoBuglio; J W Taylor
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

6.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.

Authors:  M R McGinnis; L Pasarell
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  8 in total
  4 in total

1.  In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

Authors:  C B Moore; C M Walls; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Authors:  Borann Sar; Sambo Boy; Chantary Keo; Chan Chhaya Ngeth; Narom Prak; Mich Vann; Didier Monchy; Jean Louis Sarthou
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.

Authors:  Susanna K P Lau; George C S Lo; Clare S K Lam; Wang-Ngai Chow; Antonio H Y Ngan; Alan K L Wu; Dominic N C Tsang; Cindy W S Tse; Tak-Lun Que; Bone S F Tang; Patrick C Y Woo
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Melanization and morphological effects on antifungal susceptibility of Penicillium marneffei.

Authors:  Jutikul Kaewmalakul; Joshua D Nosanchuk; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  Antonie Van Leeuwenhoek       Date:  2014-09-17       Impact factor: 2.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.